TransMedics Group Future Growth
Future criteria checks 5/6
TransMedics Group is forecast to grow earnings and revenue by 70.1% and 26.4% per annum respectively. EPS is expected to grow by 71.7% per annum. Return on equity is forecast to be 17.4% in 3 years.
Key information
70.1%
Earnings growth rate
71.7%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 26.4% |
| Future return on equity | 17.4% |
| Analyst coverage | Good |
| Last updated | 03 Apr 2024 |
Recent future growth updates
Recent updates
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24
TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16TransMedics: Game Changer Technology Will Boost Revenue Growth
Oct 20TransMedics Is A Buy Following Q2 FY22 Earnings Upside
Aug 03Is TransMedics Group (NASDAQ:TMDX) Weighed On By Its Debt Load?
Jun 12TransMedics - Impressive Transformation
May 20Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 640 | 79 | 125 | 143 | 3 |
| 12/31/2025 | 490 | 17 | 3 | 38 | 7 |
| 12/31/2024 | 367 | -2 | -96 | 20 | 7 |
| 12/31/2023 | 242 | -25 | -192 | -13 | N/A |
| 9/30/2023 | 192 | -36 | -165 | -25 | N/A |
| 6/30/2023 | 151 | -18 | -41 | -33 | N/A |
| 3/31/2023 | 119 | -28 | -47 | -36 | N/A |
| 12/31/2022 | 93 | -36 | -58 | -46 | N/A |
| 9/30/2022 | 72 | -42 | -61 | -48 | N/A |
| 6/30/2022 | 51 | -48 | -53 | -43 | N/A |
| 3/31/2022 | 39 | -47 | -45 | -40 | N/A |
| 12/31/2021 | 30 | -44 | -32 | -29 | N/A |
| 9/30/2021 | 28 | -38 | -30 | -29 | N/A |
| 6/30/2021 | 30 | -30 | -27 | -26 | N/A |
| 3/31/2021 | 25 | -28 | -30 | -29 | N/A |
| 12/31/2020 | 26 | -29 | -31 | -30 | N/A |
| 9/30/2020 | 24 | -32 | -31 | -30 | N/A |
| 6/30/2020 | 24 | -35 | -30 | -30 | N/A |
| 3/31/2020 | 26 | -36 | -34 | -33 | N/A |
| 12/28/2019 | 24 | -34 | -32 | -32 | N/A |
| 9/28/2019 | 21 | -32 | -31 | -31 | N/A |
| 6/29/2019 | 18 | -29 | -32 | -32 | N/A |
| 3/30/2019 | 15 | -26 | -27 | -27 | N/A |
| 12/29/2018 | 13 | -24 | -26 | -26 | N/A |
| 9/29/2018 | 12 | -21 | -26 | -25 | N/A |
| 6/30/2018 | 9 | -20 | -24 | -24 | N/A |
| 3/31/2018 | 8 | -20 | -23 | -23 | N/A |
| 12/30/2017 | 8 | -21 | N/A | -23 | N/A |
| 12/31/2016 | 6 | -24 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: TMDX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TMDX is expected to become profitable in the next 3 years.
Revenue vs Market: TMDX's revenue (26.4% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: TMDX's revenue (26.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TMDX's Return on Equity is forecast to be low in 3 years time (17.4%).